US Patent Issued to INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY on Nov. 3 for "Assessment methods and diagnostic kit for predicting acute antidepressant response and remission in patients with depressive disorders using multimodal serum biomarkers" (South Korean Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,782,363, issued on Nov. 3, was assigned to INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (Gwangju, South Korea).

"Assessment methods and diagnostic kit for predicting acute antidepressant response and remission in patients with depressive disorders using multimodal serum biomarkers" was invented by Jae Min Kim (Gwangju, South Korea) and Hee Ju Kang (Gwangju, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for predicting antidepressant treatment response and acute prognosis for depressed patients according to an embodiment of the present disclosure includes measuring a concentration of an antidepressant treatment response predicti...